MAPK8IP1P2: A Potential Drug Target for Cancer (G644172)

Target Name: MAPK8IP1P2

NCBI ID: G644172

MAPK8IP1P2

Other Name(s): Mitogen-activated protein kinase 8 interacting protein 1 pseudogene 2 | mitogen-activated protein kinase 8 interacting protein 1 pseudogene 2

MAPK8IP1P2: A Potential Drug Target for Cancer

MAPK8IP1P2, also known as Mitogen-activated protein kinase 8 interacting protein 1 pseudogene 2, is a protein that has been identified as a potential drug target or biomarker. The protein is a key regulator of cell proliferation and has been linked to various diseases, including cancer.

MAPK8IP1P2 is a protein that is expressed in various tissues and cells throughout the body. It is a part of the MAPK8 signaling pathway, which is a well-established pathway that is involved in various cellular processes, including cell proliferation, differentiation, and survival. The MAPK8 signaling pathway is activated by various factors, including growth factors, physical stimulation, and stress.

MAPK8IP1P2 is a protein that is known to play a negative role in the MAPK8 signaling pathway. It is part of a protein complex that is involved in regulating the activity of the MAPK8 signaling pathway. This protein complex is composed of several different proteins, including MAPK8 , MAPK8AP1, and MAPK8BP1. These proteins work together to regulate the activity of the MAPK8 signaling pathway and to ensure that it is not activated by too much or too little stimulation.

MAPK8IP1P2 has been shown to be involved in various cellular processes, including cell proliferation, differentiation, and survival. It has been linked to the development and progression of various diseases, including cancer. For example, studies have shown that MAPK8IP1P2 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. It is also involved in the regulation of cell apoptosis, which is a natural process that helps cells to eliminate themselves when they are no longer needed.

MAPK8IP1P2 is a protein that has been shown to play a negative role in the development and progression of various diseases. It is a potential drug target or biomarker that could be targeted by small molecules or other therapeutic agents. For example, studies have shown that inhibiting the activity of MAPK8IP1P2 using small molecules can lead to the inhibition of the growth and survival of various cancer cell lines.

In conclusion, MAPK8IP1P2 is a protein that has been identified as a potential drug target or biomarker. Its involvement in the MAPK8 signaling pathway and its role in the regulation of cell proliferation and apoptosis make it an attractive target for small molecules or other therapeutic agents. Further research is needed to fully understand the role of MAPK8IP1P2 in various cellular processes and to develop effective therapies that target this protein.

Protein Name: Mitogen-activated Protein Kinase 8 Interacting Protein 1 Pseudogene 2

The "MAPK8IP1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAPK8IP1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets